NVO Competitors & Alternatives

Compare Novo Nordisk A/S with similar stocks in the same industry

Drug Manufacturers - General

NVO

Main Stock
$37.32
Tradestie Score
45
Market Cap
$262.92B
P/E Ratio
9.5
Revenue Growth
0.0%
Analyst Upside
+22.7%

Top Competitors

20 stocks in Drug Manufacturers - General
Company Price Market Cap P/E Score Action
AZN AstraZeneca PLC
$156.90
$261.56B 23.6 47 Compare
NVS Novartis AG
$141.00
$254.99B 21.3 66 Compare
MRK Merck & Co., Inc.
$144.30
$225.13B 116.0 55 Compare
AMGN Amgen Inc
$403.04
$160.70B 26.2 55 Compare
PFE Pfizer Inc.
$27.80
$154.70B 37.0 53 Compare
GILD Gilead Sciences Inc
$144.74
$137.92B - 46 Compare
SNY Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
$39.92
$121.27B 22.2 39 Compare
BMY Bristol-Myers Squibb Co.
$61.15
$96.54B 13.5 54 Compare
GSK GSK plc American Depositary Shares (Each representing two Ordinary Shares)
$47.03
$91.59B 15.5 32 Compare
SMCI Super Micro Computer, Inc. Common Stock
$43.69
$31.13B 12.6 37 Compare

Data updated: Oct 03, 2026 | Industry: Drug Manufacturers - General (SIC 2834)

20 stocks in this industry